-
SNY Announces Acquisition Of BJGP
Friday, October 29, 2010 - 9:19am | 165Read More...Oppenheimer has published a research report on BMP Sunstone Corporation (NASDAQ: BJGP) after Sanofi-Aventis (NYSE: SNY) announced its acquisition of the company. In the report, Oppenheimer writes "SNY's $520M bid for BMP Sunstone underscores the attractiveness of China's growing OTC market and BJGP...
-
Buffett's Underperformers: A Good Bet On A Blue-Chip Rebound?
Monday, October 25, 2010 - 1:39pm | 334Read More...If we were all as lucky as Warren Buffett, we would be able to make investments in companies like ConocoPhillips (NYSE: COP), U.S. Bancorp (NYSE: USB-PH), Kraft Foods (NYSE: KFT), Sanofi-Aventis (NYSE: SNY), Johnson & Johnson (NYSE: JNJ) and Wells Fargo & Company (NYSE: WFC) and call them...
-
Sanofi Pasteur Wins Workplace Health Award
Monday, October 18, 2010 - 8:08am | 219Read More...This year the Who's Who in Work place Health Award for the Employee Communication category was awarded to Sanofi Pasteur Limited (NYSE: SNY). The company submitted its Phoenix Wellness Program, an integrated program that cross-promotes through seven different communications vehicles specially...
-
S&P Downgrades Genzyme (GENZ) to Hold from Buy.
Tuesday, August 31, 2010 - 10:59am | 187Read More...S&P entered into the Sanofi-Aventis (NYSE: SYN) – Genzyme (NASDAQ: GENZ) merger fray by downgrading shares of Genzyme, yesterday to Hold from Buy. S&P think the deal will get done at a higher price than the $69 a share, Sanofi has offered to purchase Genzyme. But after Genzyme’s 38% stock...
-
AstraZeneca Upgraded, Sanofi-Aventis Downgraded
Thursday, January 21, 2010 - 7:52am | 132Read More...AstraZeneca (NYSE: AZN) shares were up in early trading after Morgan Stanley (NYSE: MS) upgraded the drugmaker's stock to Overweight from Equalweight late Wednesday. "Worsening generic pressure and R&D management changes lead us to expect material cuts to internal small research spend in 2010/...
